['depression', 'depressive disorder', 'depression, postpartum', 'behavioral symptoms', 'mood disorders', 'mental disorders', 'puerperal disorders', 'pregnancy complications', 'postpartum', 'ppd']
['ganaxolone', 'placebo']

        Inclusion Criteria:

          -  Subject experienced a Major Depressive Episode, which started between the start of the
             third trimester and 4 weeks following delivery. The Major Depressive Episode must be
             diagnosed according to MINI 7.0 interview

          -  Subject gave birth in the last 6 months

          -  Subject has a HAMD17 score of ≥ 26 at screening

          -  Subject must agree to stop breastfeeding from start of study treatment or must agree
             to temporarily cease giving breast milk to her infant(s)

        Exclusion Criteria:

          -  Current or past history of any psychotic illness, including Major Depressive Episode
             with psychotic features

          -  History of suicide attempt within the past 3 years

          -  Active suicidal ideation

          -  History of bipolar I disorder

          -  History of seizure disorder
      